Systemic treatment of seborrheic dermatitis with retinol palmitate

Cover Page

Cite item


The goal of the study. Evaluating of the effectiveness of treatment of men with a diagnosis «Seborrheic dermatitis of the scalp» by the system using of retinol palmitate. Material and methods. 36 patients every day for 2 months received overnight per os 200000 ME of retinol palmitate, and in the comparison group (39 people) antiseborrheic shampoos have been used. The dynamics of severity of skin oiliness, pruritis, erythema, peeling, infiltration, excoriations has been evaluated in points. Before and after the treatment a histological and morphometric study of biopsy material from the affected areas has been carried.The terms of relapses have been set. Results. Retinol palmitate treatment efficiency - 91.7%, antiseborrheic shampoos - 84.6%. Along with the regression of symptoms of the disease in both groups after retinol palmitate treatment significantly declined oiliness of skin; the sizes of sebaceous glands acini and the presence of differentiated sebocytes, the squares of lymphocytic-macrophage clusters in the dermis, the number of keratinocytes with vacuolated cytoplasm have been reduced. Relapses of the disease during a year occured more rare - in 21 patients out of 32 (in the comparison group- in 25 out of 31) and at a later date (in the first 3 months in 2 patients out of 32, in comparison group in 10 out of 31). Identified effects were due to the action of retinol palmitate on the morphogenesis of the sebaceous glands.

About the authors

O. V. Kalinina

State-Financed Health Institution of Smolensk region «Regional Dermatovenereologic Dispensary»; Orel state university

Author for correspondence.
Russian Federation

V. I. Albanova

Federal State - «State Research Center of dermatovenereology and cosmetology», Ministry of Healthcare of Russia

Russian Federation

T. A. Belousova

Closed Joint Stock Company Pharmaceutical Research and Production Enterprise «Retinoids»

Russian Federation

V. I. Nozdrin

Closed Joint Stock Company Pharmaceutical Research and Production Enterprise «Retinoids»; Orel state university

Russian Federation


  1. Dessinioti C., Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol 2013; 31: 343-351.
  2. Gupta A.K., Richardson M., Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol 2014; 28: 16-26.
  3. Del Rosso J.Q., Kim G.K. Seborrheic dermatitis and Malassezia species: how are they related? J Clin Aesthet Dermatol 2009; 2: 14-17.
  4. Gaitanis G., Velegraki A., Mayser P., Bassukas I.D. Skin diseases associated with Malassezia yeasts: facts and controversies. Clin Dermatol 2013; 31: 455-463.
  5. Gupta A.R.,Madzia S.E., Batra R. Etiology and management of seborrheic dermatitis. Dermatology 2004; 208: 89-93.
  6. Ноздрин В.И., Альбанова В.И., Сазыкина Л.Н. Морфогенетический подход к лечению угрей ретиноидами. М: Ретиноиды 2005
  7. Everts H.B. Endogenous retinoids in the hair follicle and sebaceous gland. Biochim Biophys Acta 2012; 1821: 222-229
  8. Кубанова А.А. (ред.).Дерматовенерология: Клин. рекомендации. М: ДЭКС-ПРЕСС 2010
  9. Amado Y., Patino-Uzcategui A., Cepero de Garcia M.C. et al. Seborrheic dermatitis: predisposing factors and ITS2 secondary structure for Malassezia phylogenic analysis. Med Mycol 2013; 51: 868-875.
  10. Goldust M., Rezaee E., Raghifar R. Treatment of seborrheic dermatitis: comparison of sertaconazol 2% cream versus pimecrolimus 1% cream. Ir J Med Sci 2013; 182: 703-706.
  11. Zampeli V.A., Makrantonaki E., Tzellos T., Zouboulis C.C. New pharmaceutical concepts for sebaceous gland diseases: implementing today's preclinical data into tomorrow's daily clinical practice. Curr Pharm Biotechnol 2012; 13: 1898-1913.
  12. Афанасьев Ю.И., Ноздрин В.И., Волков Ю.Т., Никифоров С.А. Витамин А - регулирующий фактор процессов гистогенеза. Успехи соврем биол 1990; 110: 410-418
  13. Масюкова С.А., Ахмедов Н.Ш., Федоров С.М. Ретинола пальмитат в терапии вульгарных угрей. Вестн дерматол венерол 1992; (10): 36-37

Copyright (c) 2014 Kalinina O.V., Albanova V.I., Belousova T.A., Nozdrin V.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies